RecruitingNCT06417138

Comparative Effectiveness of Different Drugs Used to tr€at Patients in Rheumatoid Arthritis Saudi Database (RASD)"

Comparative Effectiveness of Different Drugs Used to Treat Patients in Rheumatoid Arthritis Saudi Database (RASD) The Primary Objective of This Study is to Compare the Effectiveness of Different Biological Disease Modifying Antirheumatic Drugs (bDMARDs) and Targeted Synthetic (tsDMARDs) Using DAS-28-CRP and CDAI Scores.

Sponsor

Umm Al-Qura University

Enrollment

800 participants

Start Date

Dec 15, 2023

Study Type

OBSERVATIONAL

Conditions

Rheumatoid Arthritis (RA)

Summary

Comparative effectiveness of different drugs used to treat patients in Rheumatoid Arthritis Saudi database (RASD) The goal of this observational study is to compare the effectiveness of different biological Disease Modifying Antirheumatic Drugs (bDMARDs) and targeted synthetic (tsDMARDs) using Disease Activity Score - 28 joints - C-Reactive Protien (DAS-28-CRP) and Clinical Disease Activity Index (CDAI) scores. In rheumatoid arthritis patients in Saudi Arabia who are part of Rheumatoid Arthritis Saudi Database (RASD). The main question\[s\] it aims to answer: * What is the most effective drug (biologocal or targeted synthetic) disease modifying antirheumatic drug used to treat rheumatoid arthritis in Saudi Arabia? * We are going to use two outcome mesures: Disease Activity Score - 28 joints - C-Reactive Protien (DAS-28-CRP) and Clinical Disease Activity Index (CDAI) scores Researchers will compare the treatment of rheumatoid arthritis using specific outcome measures in Rheumatoid Arthritis in Saudi Arabia. * Participants will be enrolled after a signed written concent in our Rheumatoid Arthritis Saudi Databas (RASD). * Their treatment data will used to compare the effectiveness of different drugs they are using.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a database in Saudi Arabia to compare the effectiveness of different medications used to treat rheumatoid arthritis (RA) — a chronic autoimmune disease causing joint pain, swelling, and stiffness. The goal is to understand which drugs work best for different patients in a real-world clinical setting. **You may be eligible if...** - You are 18 or older - You have been diagnosed with rheumatoid arthritis according to the 2010 American College of Rheumatology criteria - You are male or female - You have had at least 12 months of follow-up care with at least 3 documented clinic visits **You may NOT be eligible if...** - You do not meet the diagnostic criteria for rheumatoid arthritis - You have not had sufficient follow-up care documented Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.